News search
Research 5 Jul 2023 A multicenter study published in JAMA Cardiology and co-led by scientists at Hadassah Medical Center, Sheba Medical Center, and the CNIC could help in the design of future pharmacological treatments for bicuspid aortic valve |
Research 29 May 2023 The new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer |
Research 7 Nov 2022 A CNIC study reveals that mutations previously identified in the gene MINDBOMB1 (MIB1) as causing non-compaction cardiomyopathy either provoke this disease or valve defects, depending on their combination with mutations in modifier genes |
Research 17 Mar 2022 The mixing of mitochondrial DNAs (mtDNAs) of two distinct origins can have damaging medium- and long-term effects, according to the results of a new study published in Circulation |
Research 18 Nov 2021 Immune therapy based on nasal administration of a preparation of dead bacteria called MV130 prevents death in experimental animals infected with the SARS-CoV-2 coronavirus and increases the immunogenicity of COVID-19 vaccines |
Research 30 Aug 2021 The safety, availability, and robust biological effect of metoprolol could together be enough to consider its use in young patients admitted to the ICU with severe COVID-19 |
About the CNIC 29 Jun 2021 Over one million European cancer patients suffer from side effects to chemotherapy |
About the CNIC 9 Jun 2021 The study, published in Nature in 2019, revealed relevant data about the involvement of the protein p38gamma in the development of the main type of primary liver cancer, which affects over a million people a year worldwide |
- ‹ previous
- 2 of 4
- next ›